Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Arben Ventures is a venture fund founded by researchers from Stanford's Department of Genetics and directors of the Stanford Healthcare Innovation Lab. Based in the United States, the firm manages a $12 million fund and has made over 70 investments in early-stage health startups. The fund aims to support transformative ideas that are too advanced for academic backing but too early for traditional venture capital.
Arben Ventures invests $25,000 to $50,000 in early-stage health startups, concentrating on sectors such as precision medicine (30%), early cancer detection (15%), women's health (15%), chronic disease (15%), mental health (10%), brain and neurotechnology (10%), and robotics (5%). The firm targets advancements in genomics, multi-omics, wearables, and artificial intelligence that create opportunities in human health.
Arben Ventures has invested in over 70 companies, achieving more than $200 million in follow-on funding and four FDA clearances. Their portfolio includes companies focused on brain and neurotechnology, early cancer detection, and mental and behavioral health.
Submit your pitch through their form at arben.ventures.
Arben Ventures typically participates in early-stage funding rounds, often leading investments in their focus areas.
The firm has provided over $200 million in follow-on funding to its portfolio companies, indicating a strong commitment to supporting their growth.
Arben Ventures currently manages a $12 million fund dedicated to early-stage health startups.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.